1. AstraZeneca
2. Pfizer
Inc
3. GlaxoSmithKline plc
4. Novartis AG
5. AstellasPharma Inc.
6. Abbott Laboratories
7. BoehringerIngelheim International GmbH
8. Almirall
Published | Pages | Publisher | Report code |
---|---|---|---|
Jan 2023 | 125 | Renub Research | ASDR-613314 |
1. AstraZeneca
2. Pfizer
Inc
3. GlaxoSmithKline plc
4. Novartis AG
5. AstellasPharma Inc.
6. Abbott Laboratories
7. BoehringerIngelheim International GmbH
8. Almirall